Cargando…
Charlson comorbidity index and a composite of poor outcomes in COVID-19 patients: A systematic review and meta-analysis
BACKGROUND AND AIMS: The ongoing COVID-19 pandemic is disproportionately affecting patients with comorbidities. Therefore, thorough comorbidities assessment can help establish risk stratification of patients with COVID-19, upon hospital admission. Charlson Comorbidity Index (CCI) is a validated, sim...
Autores principales: | Tuty Kuswardhani, R.A., Henrina, Joshua, Pranata, Raymond, Anthonius Lim, Michael, Lawrensia, Sherly, Suastika, Ketut |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Diabetes India. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598371/ https://www.ncbi.nlm.nih.gov/pubmed/33161221 http://dx.doi.org/10.1016/j.dsx.2020.10.022 |
Ejemplares similares
-
Clinical frailty scale and mortality in COVID-19: A systematic review and dose-response meta-analysis
por: Pranata, Raymond, et al.
Publicado: (2021) -
The Effect of Metformin Consumption on Mortality in Hospitalized COVID-19 patients: a systematic review and meta-analysis
por: Lukito, Antonia Anna, et al.
Publicado: (2020) -
Proton pump inhibitor on susceptibility to COVID-19 and its severity: a systematic review and meta-analysis
por: Pranata, Raymond, et al.
Publicado: (2021) -
Diabetes and COVID-19: The past, the present, and the future
por: Pranata, Raymond, et al.
Publicado: (2021) -
Delirium and Mortality in Coronavirus Disease 2019 (COVID-19) – A Systematic Review and Meta-analysis
por: Pranata, Raymond, et al.
Publicado: (2021)